Extension of the generic amyloid hypothesis to nonproteinaceous metabolite assemblies
Author(s) -
Shira ShahamNiv,
Lihi AdlerAbramovich,
Lee Schnaider,
Ehud Gazit
Publication year - 2015
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.1500137
Subject(s) - amyloid (mycology) , peptide , chemistry , amyloid disease , fibril , amyloid fibril , biochemistry of alzheimer's disease , biochemistry , amyloidosis , biology , microbiology and biotechnology , amyloid β , medicine , amyloid precursor protein , alzheimer's disease , pathology , disease , inorganic chemistry
The accumulation of amyloid fibrils is the hallmark of several major human diseases. Although the formation of these supramolecular entities has previously been associated with proteins and peptides, it was later demonstrated that even phenylalanine, a single amino acid, can form fibrils that have amyloid-like biophysical, biochemical, and cytotoxic properties. Moreover, the generation of antibodies against these assemblies in phenylketonuria patients and the correlating mice model suggested a pathological role for the assemblies. We determine that several other metabolites that accumulate in metabolic disorders form ordered amyloid-like ultrastructures, which induce apoptotic cell death, as observed for amyloid structures. The formation of amyloid-like assemblies by metabolites implies a general phenomenon of amyloid formation, not limited to proteins and peptides, and offers a new paradigm for metabolic diseases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom